Ke Koʻikoʻi o ka ʻIke ʻana
He mea maʻamau ka candidiasis fungal (i ʻike ʻia hoʻi he maʻi candidal). Nui nā ʻano o Candida a meʻoi aku ma mua o 200 mau ʻano o Candida ʻēi ʻike ʻia a hiki i kēia manawa.ʻO Candida albicans (CA) ʻo ia ka mea pathogenic loa, nā moʻolelo no kahi o 70% o nā maʻi lapaʻau āpau.ʻO CA, i ʻike ʻia hoʻi ʻo Candida keʻokeʻo, he parasitize maʻamau ia ma nā membrane mucous o ka ʻili kanaka, ka waha waha, ke ala gastrointestinal, ka vagina, a me nā mea ʻē aʻe. Ke kūlike ʻole ka hana pale kino o ke kanaka a i ʻole ke kaulike ʻole o ka flora maʻamau, ʻo CA Mei ke kumu o ka maʻi ʻōnaehana kino, ka maʻi vaginal, ka maʻi ʻōpū hanu haʻahaʻa, a pēlā aku.
ʻO ka maʻi ʻōpū:Ma kahi o 75% o nā wahine e loaʻa i ka vulvovaginal candidiasis (VVC) ma ka liʻiliʻi hoʻokahi i ko lākou ola, a ʻo ka hapalua o lākou e hoʻi hou mai. Ma waho aʻe o nā hōʻailona kino ʻeha e like me ka ʻūlū a me ka wela o ka vulvovaginal, hiki i nā hihia koʻikoʻi ke hoʻomaha ʻole, kahi i ʻike nui ʻia i ka pō, a hoʻopilikia nui hoʻi i nā manaʻo a me ka noʻonoʻo o ka mea maʻi. ʻAʻohe hōʻike lapaʻau kikoʻī o VVC, a ʻo nā hoʻokolohua hoʻokolohua ke kī i ka ʻike ʻana.
ʻO ka maʻi fungal pulmonary:CA ʻo ka maʻi kahi kumu nui o ka make mai ka maʻi haukapila a he 40% ia e pili ana ima waena o nā maʻi maʻi koʻikoʻi ma ka ICU. Ua ʻike ʻia kahi noiʻi retrospective multicenter o ka maʻi fungal pulmonary ma Kina mai 1998 a 2007 ua helu ʻia ka candidiasis pulmonary no 34.2%, o ia hoʻiCA ua helu ʻia no 65% o ka candidiasis pulmonary. C hanuA ʻAʻohe o ka maʻi i nā hōʻailona lapaʻau maʻamau a he haʻahaʻa ka kikoʻī i nā hōʻike kiʻi, e paʻakikī ai ka ʻike mua ʻana. Paipai ka ʻaelike loea ma ka ʻike ʻana a me ka mālama ʻana i ka maʻi fungal pulmonary i ka hoʻohana ʻana i nā hāpana sputum kūpono i ʻū ʻia me ka hohonu, e hoʻoikaika ana i ka hoʻāʻo ʻana i ka biology molecular, a me ka hāʻawi ʻana i nā hoʻolālā lapaʻau fungal kūpono.
Nā ʻAno Laʻana

Hoʻonā ʻIke
Nā hiʻohiʻona huahana
Ka pono:Hoʻonui isothermal no ka hoʻonui maʻalahi ʻana me ka hopena i loko o 30 min;
Kūlana kiʻekiʻe: Skumu mua a me ka ʻimi (rProbe)i hoʻolālā ʻiano nā wahi i mālama nui ʻia o CAme kahi ʻōnaehana pani piha e ʻike pono i ka CA DNA i loko o nā specimens. ʻAʻohe cross-reactivity me nā pathogens maʻi urogenital ʻē aʻe;
ʻIke kiʻekiʻe: LoD o 102 bacteria/mL;
QC kūpono: ʻŌlelo kūloko exogenous e kāohi i ka reagent a me ka maikaʻi o ka hana a pale i nā maikaʻi ʻole wahaheʻe;
Nā hopena pololei: 1,000 mau hihia o nā multi-centeloiloi lapaʻau me kahika nui o ka hoʻokō ʻanaof 99.7%;
Ka uhi ākea o nā serotypes: ʻO nā serotypes āpau o Candida albicans A, B, Cuhi ʻia menā hopena kūlikehoʻohālikelike ʻia meka ʻike ʻana i ke kaʻina hana;
Nā reagents hāmama: Kūlike me ka PCR mainstream o kēia manawaʻōnaehanatnā em.
ʻIke Huahana
| Kōmike Huahana | Inoa Huahana | Nā kikoʻī | Helu Palapala Hōʻoia. |
| HWTS-FG005 | Pahu ʻIke Waikawa Nucleic e pili ana i ka Enzymatic Probe Isothermal Amplification (EPIA) no Candida Albicans | 50 mau hoʻāʻo/kit | |
| HWTS-EQ008 | Hoʻonui maʻalahiʻŌnaehana ʻIke Isothermal Fluorescence manawa maoli | HWTS-1600P 4 nā kahawai fluorescence | NMPA2023322059 |
| HWTS-EQ009 | HWTS-1600s 2nā kahawai fluorescence |
Ka manawa hoʻouna: Iulai-15-2024
